Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -97.15%10.03M | ---- | -14.19%352.27M | ---- | -41.16%410.53M | ---- | 21.52%697.71M | 39.55%493.37M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -7,194.87%-5.69M | ---- | 32.76%-78K | ---- | 98.71%-116K | ---- | 24.79%-9.01M | -9.85%-7.2M | ---- |
| Attributable subsidiary (profit) loss | ---- | 900.73%5.52M | ---- | 86.21%-689K | ---- | 53.17%-5M | ---- | 3.73%-10.67M | 13.65%-8.6M | ---- |
| Impairment and provisions: | ---- | 96.62%30M | ---- | 345.62%15.26M | ---- | -71.39%3.42M | ---- | 147.02%11.97M | 91.07%8.3M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | --10.37M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 28.65%19.63M | ---- | 345.62%15.26M | ---- | -73.45%3.42M | ---- | 166.17%12.9M | 91.07%8.3M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---928K | ---- | ---- |
| Asset sale loss (gain): | ---- | 2,053.33%323K | ---- | -98.50%15K | ---- | 107.30%1M | ---- | -171,575.00%-13.73M | 225.00%10K | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | 103.20%439K | ---- | ---13.71M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 2,053.33%323K | ---- | -97.34%15K | ---- | 2,356.00%564K | ---- | ---25K | 225.00%10K | ---- |
| Depreciation and amortization: | ---- | 23.82%318.53M | ---- | 15.73%257.26M | ---- | 39.13%222.3M | ---- | 74.91%159.77M | 77.30%113.77M | ---- |
| -Amortization of intangible assets | ---- | 17.85%17.72M | ---- | 21.39%15.04M | ---- | 81.49%12.39M | ---- | 82.78%6.83M | 279.23%5.09M | ---- |
| Financial expense | ---- | 15.52%117.26M | ---- | 10.30%101.5M | ---- | 76.70%92.03M | ---- | 327.33%52.08M | 387.41%32.21M | ---- |
| Special items | ---- | --547K | ---- | ---- | ---- | ---- | ---- | ---- | 81.30%-1.78M | ---- |
| Operating profit before the change of operating capital | ---- | -34.32%476.51M | ---- | 0.19%725.53M | ---- | -18.46%724.17M | ---- | 36.65%888.12M | 56.50%630.07M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 38.14%-7.06M | ---- | -16.68%-11.41M | ---- | -130.79%-9.78M | ---- | -339.71%-4.24M | -321.28%-3.61M | ---- |
| Accounts receivable (increase)decrease | ---- | 151.42%78.22M | ---- | -15.70%-152.1M | ---- | 26.83%-131.46M | ---- | 33.59%-179.67M | 37.17%-84.83M | ---- |
| Accounts payable increase (decrease) | ---- | -98.90%1.22M | ---- | 784.38%110.74M | ---- | -90.72%12.52M | ---- | 10.24%134.9M | -55.12%60.25M | ---- |
| Special items for working capital changes | ---- | -622.30%-82.73M | ---- | 159.74%15.84M | ---- | 122.88%6.1M | ---- | 25.51%-26.65M | 112.86%1.97M | ---- |
| Cash from business operations | 8.75%284M | -32.30%466.16M | -13.69%261.15M | 14.47%688.61M | 14.28%302.56M | -25.96%601.54M | -15.53%264.75M | 73.70%812.46M | 55.57%603.85M | 39.36%313.43M |
| Other taxs | -1.05%-15.78M | 44.22%-32.08M | 38.67%-15.62M | 1.79%-57.5M | -12.01%-25.47M | -30.86%-58.55M | -40.63%-22.73M | -213.32%-44.74M | -217.65%-27.03M | -905.97%-16.17M |
| Adjustment items of business operations | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 9.24%268.21M | -31.22%434.08M | -11.71%245.53M | 16.23%631.11M | 14.91%278.1M | -29.27%542.99M | -18.59%242.01M | 69.30%767.72M | 51.93%576.82M | 33.12%297.27M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 7,194.87%5.69M | ---- | -32.76%78K | ---- | -99.10%116K | ---- | 9.72%12.87M | 12.49%7.32M | ---- |
| Dividend received - investment | ---- | -55.53%1.4M | ---- | -67.28%3.15M | ---- | 50.31%9.62M | ---- | 43.82%6.4M | 94.44%5.25M | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 59.80%150M | --150M | 412.89%93.87M | ---- | ---- |
| Decrease in deposits (increase) | -347.28%-10M | 200.00%4.04M | --4.04M | -340.71%-4.04M | ---- | -94.40%1.68M | ---- | 194.70%30.02M | 146.18%10.02M | ---- |
| Sale of fixed assets | 379.38%465K | 1,091.80%727K | --97K | -98.01%61K | ---- | 136.24%3.06M | ---- | 218.67%1.3M | 539.80%627K | ---- |
| Purchase of fixed assets | 51.96%-176.17M | 27.14%-560.13M | 19.38%-366.69M | 46.64%-768.77M | 34.30%-454.85M | 20.11%-1.44B | 13.80%-692.27M | -25.54%-1.8B | -30.73%-1.31B | -41.82%-803.13M |
| Purchase of intangible assets | 86.81%-1.99M | 51.12%-28.91M | -22.53%-15.11M | -20.36%-59.15M | 27.12%-12.33M | 89.29%-49.14M | 13.21%-16.92M | -830.23%-458.8M | -1,193.27%-374.74M | -91.64%-19.5M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -85.73%5.71M | ---- | --39.97M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | 10.33%-90.65M | ---- | -52.45%-101.09M | -85.47%-69.18M | -229.43%-66.31M | -229.43%-66.31M | -73.01%-37.3M |
| Recovery of cash from investments | ---- | --45M | --45M | ---- | ---- | --15M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 85.29%-8M | ---8M | -3,092.49%-54.4M | ---- | 95.54%-1.7M | ---- | 54.34%-38.22M | -1,100.00%-14.4M | ---- |
| Other items in the investment business | 30.86%2.96M | ---- | 169.10%2.27M | ---- | -1,331.44%-3.28M | ---- | -107.31%-229K | ---- | ---- | 111.43%3.13M |
| Net cash from investment operations | 45.41%-184.74M | 44.52%-540.18M | 28.07%-338.4M | 30.81%-973.72M | 25.16%-470.46M | 35.50%-1.41B | 26.63%-628.6M | -33.50%-2.18B | -60.70%-1.74B | -34.84%-856.79M |
| Net cash before financing | 189.89%83.48M | 69.03%-106.1M | 51.73%-92.87M | 60.36%-342.62M | 50.24%-192.37M | 38.89%-864.38M | 30.91%-386.59M | -19.75%-1.41B | -65.44%-1.16B | -35.76%-559.53M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -52.88%367.26M | 38.31%1.69B | 6.27%779.45M | -36.51%1.22B | -37.45%733.43M | -19.38%1.93B | 86.83%1.17B | 35.33%2.39B | 30.76%1.5B | -11.66%627.61M |
| Refund | -124.11%-1.13B | -278.88%-2.8B | -22.49%-505.56M | 38.13%-739.33M | 29.73%-412.74M | -63.80%-1.2B | -140.68%-587.38M | -38.68%-729.57M | -36.03%-491.41M | 27.36%-244.05M |
| Issuance of bonds | --1B | --1.5B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 42.41%-45.12M | 3.96%-139.98M | -10.01%-78.34M | -10.90%-145.75M | -15.87%-71.21M | -61.82%-131.42M | -124.95%-61.46M | -193.57%-81.21M | -228.66%-52.63M | ---27.32M |
| Dividends paid - financing | ---- | -138.75%-51.33M | ---- | ---21.5M | ---- | ---- | ---- | -948.03%-228.07M | ---- | ---- |
| Absorb investment income | 950.91%12.08M | -37.35%10.17M | -78.76%1.15M | -50.06%16.23M | -75.43%5.41M | -70.25%32.51M | -77.14%22.01M | -72.81%109.27M | -70.85%108.32M | -72.47%96.3M |
| Issuance expenses and redemption of securities expenses | ---- | ---547K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -810.53%-14.27M | 95.27%-700K | 88.94%-1.57M | 83.36%-14.8M | 85.77%-14.16M | -2.63%-88.95M | -184.44%-99.52M | -320.65%-86.67M | -67.45%-34.5M | -21.45%-34.99M |
| Net cash from financing operations | -4.20%186.93M | -34.94%205.46M | -18.94%195.13M | -41.66%315.82M | -46.05%240.73M | -60.54%541.32M | 6.86%446.19M | -12.64%1.37B | -6.39%1.03B | -38.02%417.56M |
| Net Cash | 164.41%270.41M | 470.72%99.37M | 111.47%102.27M | 91.70%-26.8M | -18.87%48.36M | -657.08%-323.06M | 141.98%59.61M | -110.97%-42.67M | -134.00%-134.33M | -154.28%-141.97M |
| Begining period cash | 40.35%345.62M | -9.82%246.25M | -9.82%246.25M | -54.19%273.06M | -54.19%273.06M | -6.68%596.11M | -6.68%596.11M | 155.82%638.78M | 155.82%638.78M | 155.82%638.78M |
| Cash at the end | 76.75%616.03M | 40.35%345.62M | 8.43%348.52M | -9.82%246.25M | -50.98%321.42M | -54.19%273.06M | 31.99%655.72M | -6.68%596.11M | -21.76%504.45M | -2.83%496.81M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.